ankia coetzee

Lover of elegant medicine, believer in homeostasis, follower of authenticity, investor in transgenerational metabolic karma and visionary in training.

[Scott Isaacs @scottisaacsmd]

Analysis of the SELECT trial showed that #semaglutide reduced the risks of major adverse cardiovascular events and heart failure, irrespective of A1c.
https://t.co/uCb2P5E8mB

[Prof Kamlesh Khunti @kamleshkhunti]

Our paper led by Ed Gregg now published

The burden of diabetes-associated multiple long-term conditions (multimorbidity) on years of life spent and lost

@NatureMedicine

https://t.co/MBXibaHJfn

@ClareHambling

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Michael Bergman comments on:
#Prediabetes remission in people with #obesity https://t.co/U3FxMldUcd #prediabetes

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Online—Efficacy and safety of once-weekly #semaglutide 2·4 mg versus placebo in people with #obesity and #prediabetes (#STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial https://t.co/cGSxQVTQzG #prediabetes

[Prof Kamlesh Khunti @kamleshkhunti]

We have plethora of evidence based strategies

But the evidence doesn't get implemented in clinical practice

Review in @DiabetesCareADA
@ADA_Pubs

The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice

https://t.co/ftPICByamB

@ClareHambling

[Daniel J Drucker @DanielJDrucker]

Data from clinical trials suggests that semaglutide may reduce the risks of #AtrialFibrillation #T2D https://t.co/pj7IamEsMB

[Clinical Thyroidology @clinicalthyroid]

The July issue is available! Expert reviews on new published insights in clinical #thyroid care. Follow for updates & latest reads.

https://t.co/uGSp3KsBDd

#clinicalthyroidology #endotwitter #medtwitter #thyroidcancer #hypothyroidism #hyperthyroidism @AmThyroidAssn @Medscape

[Prof Kamlesh Khunti @kamleshkhunti]

Early pregnancy HbA1c - A simple screening test for gestational diabetes

Will greatly reduce the need for OGTTs.

@ponnsara @drmohanv et al

https://t.co/RUApmhTEvq

[Prof Kamlesh Khunti @kamleshkhunti]

MHRA approves semaglutide to reduce risk of serious heart problems in obese or overweight adults

https://t.co/p0SBgp56vl

@ClareHambling

[Clinical Thyroidology @clinicalthyroid]

Drs. Sofie Bliddal, Ulla Feldt-Rasmussen, & Huma Ahmed provide review of new study in @thyroidjournal: #levothyroxine may be associated w/ lower risk of #pregnancy loss & higher #SGA risk in 1st-trimestr pts w/ #TSH 2.5-10 mIU/L

https://t.co/cmAXbQo5La

#thyroid #hypothyroid

[Nature Reviews Endocrinology @NatureRevEndo]

New content online: Graves disease: latest understanding of pathogenesis and treatment options https://t.co/BBlMOWTPTx

[Nature Reviews Endocrinology @NatureRevEndo]

New content online: The genetics behind age at menarche https://t.co/w48dLiOC0t

[Prof Kamlesh Khunti @kamleshkhunti]

As always a lovely Perspective article by none other then @DanielJDrucker

"The benefits of GLP-1 drugs beyond obesity"

A number of trials ongoing

"Will expand the utility of GLP-1 therapeutics beyond currently established cardiometabolic disorders"

https://t.co/2YiLITBdQl

[Clinical Thyroidology @clinicalthyroid]

It’s #RadioFrequencyAblation vs. #surgery for some low-risk papillary #thyroidcancer is this new #JCEM study. Summary by Dr. Sana Ghaznavi on which is better.

https://t.co/aH3Paol2YH

#medtwitter #endotwitter #thyroid @ThyCaIncm @EndoSocJournals @leonardograngel @NASITablate

[ISE @isendo]

🎬A new episode of our MEDBuzz series is now available!

In this video, Dr. Ankia Coetzee discusses preventing diabetes with newer medications, highlighting the effectiveness of GLP-1/GIP, especially when combined with weight loss strategies.

Watch here: https://t.co/oSrPI7yBeR

[Diabetologia @DiabetologiaJnl]

#Diabetes prevalence in hospital and staff workload are increasing. Implementing clinical guidelines for safer and effective inpatient diabetes care remains challenging. Harnessing #DiabetesTechnology in hospital – the way forward? #Review https://t.co/F9Gy5EgdpK 🔓

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

#Endocrine complications occur in 40–60% of #survivors of #cancer and include hypothalamic–pituitary disorders, dysregulation of steroid and peptide hormones, and dysregulation of bone and metabolism https://t.co/Vr9Ck8GMsp
#OpenAccess

[Daniel J Drucker @DanielJDrucker]

Non-nutritive sweeteners @MolMetab No evidence for deleterious metabolic effects in mice following prolonged exposure https://t.co/6GuAn2ovGu #diabetes #obesity

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Causes, prevention, and management of #diabetes-related #foot #ulcers https://t.co/PyIAbUNiFh #T1D #T2D

[Prof Kamlesh Khunti @kamleshkhunti]

Nice review

The use of technology in T2 diabetes those at high risk of T2 diabetes

https://t.co/1O63CkQw6r

@WilmotEmma @LalanthaL et al